Glycosphingolipids and drug resistance
- 31 December 2006
- journal article
- review article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1758 (12), 2096-2103
- https://doi.org/10.1016/j.bbamem.2006.08.012
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- The Role of Arachidonic Acid Regulatory Enzymes in Colorectal DiseaseDiseases of the Colon & Rectum, 2005
- Up-regulation of lactosylceramide synthase in MDR1 overexpressing human liver tumour cellsFEBS Letters, 2005
- Gangliosides of organ-confined versus metastatic androgen-receptor-negative prostate cancerBiochemical and Biophysical Research Communications, 2004
- Clinical Relevance of P-Glycoprotein in Drug TherapyDrug Metabolism Reviews, 2003
- Differential Chemosensitizing Effect of Two Glucosylceramide Synthase Inhibitors in Hepatoma CellsBiochemical and Biophysical Research Communications, 2001
- Elevation of glucosylceramide in multidrug-resistant cancer cells and accumulation in cytoplasmic dropletsInternational Journal of Cancer, 2001
- Tamoxifen retards glycosphingolipid metabolism in human cancer cellsFEBS Letters, 1996
- Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signalsCell, 1995
- The mdrl gene, responsible for multidrug-resistance, codes for P-glycoproteinBiochemical and Biophysical Research Communications, 1986
- The biosynthesis of plasmalogens in a cell‐free systemFEBS Letters, 1970